×
About 338 results

ALLMedicine™ Enterocutaneous Fistula Center

Research & Reviews  124 results

A novel technique for large lateral enterocutaneous fistula management after intestinal...
https://doi.org/10.1111/petr.14105
Pediatric Transplantation; Oliva AR, Violo Gonzalez P et. al.

Jul 31st, 2021 - Enterocutaneous fistula (ECF) is a serious and complex problem when affecting children, being responsible for a high morbidity burden, with an estimated mortality rate of 10 to 20%. There are many therapeutic options, including surgery and a wide ...

A Case of Iliopsoas Abscess and Ileitis With Enterocutaneous Fistula Caused by a Toothp...
https://doi.org/10.1093/ibd/izab118
Inflammatory Bowel Diseases; Kang MJ, Kim HW et. al.

Jun 6th, 2021 - A Case of Iliopsoas Abscess and Ileitis With Enterocutaneous Fistula Caused by a Toothpick Mimicking Small Bowel Crohn's Disease.|2021|Kang MJ,Kim HW,Park SB,Kang DH,Choi CW,|

Endoscopic Treatment of Enterocutaneous Fistulas in Crohn's Disease.
https://doi.org/10.1097/DCR.0000000000001995
Diseases of the Colon and Rectum; Yzet C, Brazier F et. al.

May 16th, 2021 - Management of enterocutaneous fistulas in Crohn's disease is challenging. The majority of patients still need intestinal resection in the biologic era. The aim of this study was to evaluate the efficacy of endoscopic treatment for enterocutaneous ...

Enterocutaneous fistula caused by Richter's femoral hernia in the elderly.
https://doi.org/10.1136/postgradmedj-2021-140120
Postgraduate Medical Journal; Cheng L, Wu Z et. al.

May 2nd, 2021 - Enterocutaneous fistula caused by Richter's femoral hernia in the elderly.|2021|Cheng L,Wu Z,Liu G,Wang F,|

Enterocutaneous fistula closure using a balloon-assisted enteroscope preloaded with an ...
https://doi.org/10.1055/a-1471-2037
Endoscopy Mulki R, Ahmed A et. al.

Apr 29th, 2021 - Enterocutaneous fistula closure using a balloon-assisted enteroscope preloaded with an over-the-scope clip - narrowing the gap.|2021|Mulki R,Ahmed A,Kyanam K,Peter S,|

see more →

Clinicaltrials.gov  6 results

Teduglutide for Enterocutaneous Fistula (ECF)
https://clinicaltrials.gov/ct2/show/NCT02889393

Sep 18th, 2018 - Eligible patients will be initially randomly assigned to either daily subcutaneous teduglutide injections (0.05 mg/kg/d) for 8 weeks or continued standard of care for 8 weeks. After 8 weeks, the groups will cross over.

A Prospective Case Series Evaluating Surgimend Mp® In Patients Undergoing Complex Abdominal Hernia Repair
https://clinicaltrials.gov/ct2/show/NCT03450473

Mar 1st, 2018 - Large abdominal wall hernias are surgically challenging to repair and often associated with significant postoperative complications. Risk factors associated with surgical site complications, such as infection and wound dehiscence, include obesity,...

Assessment of Relation Between Recurrence of Enterocutaneous Fistula and Preoperative C-reactive Protein Level After Complete Surgical Repair
https://clinicaltrials.gov/ct2/show/NCT03302598

Oct 6th, 2017 - There is a controversy in timing of operation. The timing depends on clinical assessment, laboratory tests and radiological investigations. The cornerstone of this decision is to control sepsis and inflammatory condition before surgery. This issue...

Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue
https://clinicaltrials.gov/ct2/show/NCT01157650

Nov 8th, 2016 - The aim of this study is to evaluate the role of Autologous Mesechymal Stem Cells derived from adipose tissue in the treatment of fistulous Crohn disease. 15 Crohn's disease patients with one or more enterocutaneous, recto-vaginal or complex peria...

Molecular Characteristics of the Persistent Intestinal Fistulae After Glue Application
https://clinicaltrials.gov/ct2/show/NCT01990833

Nov 25th, 2013 - For non-healing ulcers, abnormal periods of wound healing processes: inflammation, proliferation and remodelling, are believed to lead to chronic wounds. As a chronic "stalled" wound, investigators hypothesized that these glue-assisted closure (GA...

see more →

News  5 results

Fast Five Quiz: Bladder Cancer Management
https://reference.medscape.com/viewarticle/919964_5

Jan 13th, 2020 - Ileus is the most common early complication of RC. The most common late complications of RC are small-bowel obstruction and ureteroenteric anastomotic stricture. Other common complications following RC include the following: Wound infection Sepsis...

VIDEO: Endoscopy surpasses surgery for acute necrotizing pancreatitis
https://www.mdedge.com/internalmedicine/article/149613/endoscopy/video-endoscopy-surpasses-surgery-acute-necrotizing
Mitchel L. Zoler

Oct 17th, 2017 - ORLANDO – An endoscopic approach to treatment of acute necrotizing pancreatitis was substantially safer than was minimally invasive surgical treatment in a randomized study of 66 patients. Performing drainage and necrosectomy endoscopically in 34.

Medical Management Effective for Intra-Abdominal Abscesses
https://www.mdedge.com/familymedicine/article/48843/gastroenterology/medical-management-effective-intra-abdominal-abscesses
Internal Medicine News; Mary Ann Moon

Mar 8th, 2012 - For patients with Crohn’s disease who have intra-abdominal abscesses, percutaneous drainage plus anti–tumor necrosis factor therapy can be as effective as surgery, Dr. Douglas L.

Conservative Approach Best for Necrotizing Pancreatitis
https://www.medpagetoday.com/gastroenterology/pancreaticdiseases/19681

Apr 22nd, 2010 - Action Points Explain to interested patients that in this study percutaneous drainage obviated the need for necrosectomy in about a third of patients with necrotizing pancreatitis with infected necrotic tissue. A stepped approach of percutaneous d...

Rectovaginal Nodularity, Bowel Perforations Tied
https://www.mdedge.com/obgyn/article/50328/gynecology/rectovaginal-nodularity-bowel-perforations-tied
Jane Salodof MacNeil

SAN ANTONIO — Rectovaginal nodularity turned out to be the only significant risk factor for bowel complications in a retrospective single-institution study of 112 women treated with bevacizumab for recurrent epithelial ovarian cancer. Ten women (9.

see more →